Divers Jasmin, Ma Lijun, Brown William Mark, Palmer Nicholette D, Choi Young, Israni Ajay K, Pastan Stephen O, Julian Bruce A, Gaston Robert S, Hicks Pamela J, Reeves-Daniel Amber M, Freedman Barry I
Division of Health Services Research, Department of Foundations of Medicine, NYU Long Island School of Medicine and NYU Winthrop Research Institute, Mineola, NY, USA.
Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Clin Transplant. 2020 Jun;34(6):e13827. doi: 10.1111/ctr.13827. Epub 2020 Apr 25.
Two renal-risk variants in the apolipoprotein L1 gene (APOL1) in African American (AA) deceased donors (DD) are associated with shorter renal allograft survival after transplantation. To identify additional genes contributing to allograft survival, a genome-wide association study was performed in 532 AA DDs. Phenotypic data were obtained from the Scientific Registry of Transplant Recipients. Association and single-nucleotide polymorphism (SNP)-by-APOL1 interaction tests were conducted using death-censored renal allograft survival accounting for relevant covariates. Replication and inverse-variance-weighted meta-analysis were performed using data from 250 AA DD in the Genomics of Transplantation study. Accounting for APOL1, multiple SNPs near the Nudix Hydrolase 7 gene (NUDT7) showed strong independent effects (P = 1.6 × 10 -2.2 × 10 ). Several SNPs in the Translocation protein SEC63 homolog (SEC63; P = 2 × 10 -3.7 × 10 ) and plasmacytoma variant translocation 1 (PVT1) genes (P = 4.0 × 10 -7 × 10 ) modified the effect of APOL1 on allograft survival. SEC63 is expressed in human renal tubule cells and glomeruli, and PVT1 is associated with diabetic kidney disease. Overall, associations were detected for 41 SNPs (P = 2 × 10 -5 × 10 ) contributing independently or interacting with APOL1 to impact renal allograft survival after transplantation from AA DD. Given the small sample size of the discovery and replication sets, independent validations and functional genomic efforts are needed to validate these results.
非洲裔美国(AA)已故供体(DD)中载脂蛋白L1基因(APOL1)的两个肾脏风险变异与移植后肾移植存活时间缩短有关。为了确定影响移植肾存活的其他基因,对532名AA DD进行了全基因组关联研究。表型数据来自移植受者科学登记处。使用考虑了相关协变量的死亡截尾肾移植存活情况进行关联分析和单核苷酸多态性(SNP)与APOL1的相互作用测试。利用移植基因组学研究中250名AA DD的数据进行重复验证和逆方差加权荟萃分析。考虑到APOL1,Nudix水解酶7基因(NUDT7)附近的多个SNP显示出强烈的独立效应(P = 1.6×10 - 2.2×10)。转运蛋白SEC63同源物(SEC63;P = 2×10 - 3.7×10)和浆细胞瘤变异易位1(PVT1)基因中的几个SNP(P = 4.0×10 - 7×10)改变了APOL1对移植肾存活的影响。SEC63在人肾小管细胞和肾小球中表达,PVT1与糖尿病肾病有关。总体而言,检测到41个SNP存在关联(P = 2×10 - 5×10),这些SNP独立作用或与APOL1相互作用,影响AA DD移植后肾移植的存活。鉴于发现集和重复验证集的样本量较小,需要进行独立验证和功能基因组学研究来验证这些结果。